Strong Financial Performance: Cardinal Health reported a solid fourth quarter with operating earnings growth of 19%, EPS growth of 13%, and adjusted free cash flow of $2.5 billion, significantly exceeding initial expectations by $500 million.

Guidance Adjustments for FY26: The adjusted EPS guidance for fiscal year 2026 has been raised to a range of $9.30 to $9.50, reflecting an increase of $0.20 primarily due to higher expectations for pharmaceutical growth and improved contributions from the Other growth businesses.

Acquisition Strategies: The acquisition of Solaris Health is expected to enhance Cardinal Health's position in the Specialty market, boosting its multi-specialty MSO platform with an additional 750 providers across 14 states. This strategic move aligns with the company¡¯s focus on strengthening its core and expanding in Specialty.